These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30740890)

  • 1. Significance of methylation status of MASPIN gene and its protein expression in prognosis of gallbladder cancer.
    Baghel K; Kazmi HR; Chandra A; Raj S; Srivastava RN
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e120-e125. PubMed ID: 30740890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of maspin mRNA as a predictor of survival in stage II and III gallbladder cancer cases.
    Baghel K; Kazmi HR; Raj S; Chandra A; Srivastava RN
    Asian Pac J Cancer Prev; 2014; 15(1):343-7. PubMed ID: 24528054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes.
    Singh TD; Gupta S; Shrivastav BR; Tiwari PK
    Gene; 2016 Feb; 576(2 Pt 2):743-52. PubMed ID: 26456195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress and deregulations in base excision repair pathway as contributors to gallbladder anomalies and carcinoma - a study involving North-East Indian population.
    Singh N; Kazim SN; Sultana R; Tiwari D; Borkotoky R; Kakati S; Nath Das N; Kumar Saikia A; Bose S
    Free Radic Res; 2019 May; 53(5):473-485. PubMed ID: 31117842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells.
    Lin N; Yao Z; Xu M; Chen J; Lu Y; Yuan L; Zhou S; Zou X; Xu R
    J Exp Clin Cancer Res; 2019 Jun; 38(1):244. PubMed ID: 31174563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression.
    Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
    Tumour Biol; 2011 Feb; 32(1):23-32. PubMed ID: 20697987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wogonin, an active ingredient of Chinese herb medicine Scutellaria baicalensis, inhibits the mobility and invasion of human gallbladder carcinoma GBC-SD cells by inducing the expression of maspin.
    Dong P; Zhang Y; Gu J; Wu W; Li M; Yang J; Zhang L; Lu J; Mu J; Chen L; Li S; Wang J; Liu Y
    J Ethnopharmacol; 2011 Oct; 137(3):1373-80. PubMed ID: 21855619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.
    Igarashi K; Yamashita K; Katoh H; Kojima K; Ooizumi Y; Nishizawa N; Nishiyama R; Kawamata H; Tajima H; Kaizu T; Kumamoto Y; Watanabe M
    PLoS One; 2017; 12(11):e0188178. PubMed ID: 29161283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Expression of MicroRNA335-5p Is Associated with Malignant Behavior of Gallbladder Cancer: A Clinicopathological Study.
    Fatima N; Srivastava AN; Nigam J; Raza ST; Rizvi S; Siddiqui Z; Kumar V
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1895-1900. PubMed ID: 31244315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of survivin in resected gallbladder cancer.
    Nigam J; Chandra A; Kazmi HR; Parmar D; Singh D; Gupta V
    J Surg Res; 2015 Mar; 194(1):57-62. PubMed ID: 25472573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer.
    Hirosawa T; Ishida M; Ishii K; Kanehara K; Kudo K; Ohnuma S; Kamei T; Motoi F; Naitoh T; Selaru FM; Unno M
    PLoS One; 2018; 13(11):e0206643. PubMed ID: 30395583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of survivin mRNA in gallbladder cancer: a diagnostic and prognostic marker?
    Nigam J; Chandra A; Kazmi HR; Parmar D; Singh D; Gupta V; M N
    Tumour Biol; 2014 Sep; 35(9):9241-6. PubMed ID: 24935470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
    Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
    J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c‑Jun suppresses the expression of WNT inhibitory factor 1 through transcriptional regulation and interaction with DNA methyltransferase 1 in gallbladder cancer.
    Lin B; Hong H; Jiang X; Li C; Zhu S; Tang N; Wang X; She F; Chen Y
    Mol Med Rep; 2018 Jun; 17(6):8180-8188. PubMed ID: 29693707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers.
    Ogasawara S; Maesawa C; Yamamoto M; Akiyama Y; Wada K; Fujisawa K; Higuchi T; Tomisawa Y; Sato N; Endo S; Saito K; Masuda T
    Oncogene; 2004 Feb; 23(5):1117-24. PubMed ID: 14743202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of hsa‑miR‑372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1.
    Zhou N; Cheng W; Peng C; Liu Y; Jiang B
    Mol Med Rep; 2017 Nov; 16(5):7848-7854. PubMed ID: 28944858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of
    Tekcham DS; Poojary SS; Bhunia S; Barbhuiya MA; Gupta S; Shrivastav BR; Tiwari PK
    Indian J Med Res; 2016 May; 143(Supplement):S82-S90. PubMed ID: 27748282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Downregulation of PTEN in Gallbladder Cancer.
    Tekcham DS; Gupta S; Shrivastav BR; Tiwari PK
    J Gastrointest Cancer; 2017 Mar; 48(1):110-116. PubMed ID: 28124240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of MASPIN expression and subcellular localization in non-small cell lung cancer.
    Wang XF; Liang B; Zeng DX; Lei W; Chen C; Chen YB; Huang JA; Gu N; Zhu YH
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent Downregulation and Promoter Hypermethylation of DLC1: Relationship with Clinical Outcome in Gallbladder Cancer.
    Singh D; Bharti A; Biswas D; Tewari M; Kar AG; Ansari MA; Singh S; Narayan G
    J Gastrointest Cancer; 2022 Jun; 53(2):237-244. PubMed ID: 33417200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.